AMSBIO: Ebola Antigens and Antibodies for ELISA

AMSBIO has announced several products suitable for the development of an ELISA detection assay for the Ebola virus.

The new products comprise 3 different monoclonal antibodies to the Ebola virus and 2 recombinant proteins (from the Sudan and Zaire strains) suitable for use in producing an optimised ELISA test kit for Ebola. An antigen-capture enzyme-linked immunosorbant assay (ELISA) test for Ebola offers the possibility of diagnosis within the first few days after symptoms begin.

Ebola, also known as Ebola hemorrhagic fever, is a disease that typically occurs in outbreaks in the tropical regions of Sub-Saharan Africa. It is caused by four different Ebola species in humans: Bundibugyo evolavirus, Sudan ebolavirus, Taï Forest ebolavirus andZaire ebolavirus, which is the most dangerous. The first known outbreak occurred in 1976 and the largest outbreak to date is the ongoing 2014 West Africa Ebola virus outbreak-which is affecting Guinea, Sierra Leone, Liberia and Nigeria.

Diagnosing Ebola can be a challenge because the early symptoms are nonspecific to Ebola infection and are often seen in patients with more commonly occurring diseases, such as malaria and typhoid fever. Accurate diagnostics are essential in controlling an outbreak. Ideally a test should be an easy-to-use and affordable solution that enables the rapid screening of suspected patients and people travelling out of an outbreak region.

For further information please visit  www.amsbio.com/Ebola-Antigens-and-Antibodies-for-ELISA.aspx  or contact AMSBIO on on+44-1235-828200 (Europe / ROW) / +1-800-987-0985 (North America) or email info@amsbio.com.

Founded in 1987, AMS Biotechnology (AMSBIO) is recognised today as a leading company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO is able to draw upon in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. Widely acknowledged as an expert in cell culture, AMSBIO partners with clients in tailoring cell systems to enhance organoid and spheroid type screening outcomes from a technological and cost-effective perspective. Custom services include stable cell line production, CRISPR/Cas9 Genome Editing, lentivirus and adenovirus production, large scale protein production and a comprehensive portfolio of antibody services.

---------------------

Worldwide HQ 

AMS Biotechnology (AMSBIO)

184 Milton Park
Abingdon

Oxon OX14 4SE

UK

Tel: +44-1235-828200
Fax: +44-1235-820482
Email: info@amsbio.com 
Web www.amsbio.com

 

 

North American HQ

 

AMSBIO LLC
1035 Cambridge Street
Cambridge
MA 02141
USA

Tel:      +1.617.945.5033 
Tel:      +1.800.987.0985 (toll free)
Email: info@amsbio.com 
Web www.amsbio.com